Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-08-03
Werner Robert F. Files Twist Bioscience (TWST) Form 4 - August 03, 2026
Werner Robert F. sold 167 TWST shares worth $14.2K in this Form 4 filing, reported to the SEC on 2026-08-03.
- Insider
- Werner Robert F.
- Issuer
- Twist Bioscience Corporation TWST · NASDAQ
- Filed
- Period
- 2026-08-03
- Accession
- 0001214659-26-009654
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Werner Robert F. | 2026-08-03 | Sell | 167 | $85.32 | $14.2K | Direct |
| Net change | −167 | −$14.2K | ||||
About Twist Bioscience Corporation
Twist Bioscience Corporation is a pioneering biotechnology firm revolutionizing the field of synthetic DNA. The company's primary function is to produce synthetic DNA using a proprietary silicon-based manufacturing platform, enabling the creation of high-quality, accurate, and cost-effective DNA at scale. Twist Bioscience's innovations impact multiple sectors, including pharmaceuticals, industrial chemicals, agriculture, and data storage, offering transformative solutions in drug development, crop protection, and genomic research. By leveraging its proprietary DNA synthesis platform, Twist Bioscience plays a vital role in the broader biotechnology market, facilitating advancements that drive progress in personalized medicine and sustainable practices. With its cutting-edge technology, the company provides researchers and businesses with access to a wide array of DNA products and solutions essential for scientific discovery and technological innovation, underpinning its significance in the expanding biotech landscape.
Track TWST insider activity
Get alerted when Twist Bioscience Corporation executives buy or sell their shares.